Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary information to make better business and process decisions. The Evaluating Biopharma podcast is a reproduction of content originally presented at recent Evaluating Biopharma digital and educational networking events.
Evaluating Biopharma
Claim This Podcastby Evaluating Biopharma
5.0(5 reviews)
25 episodes
Updated Weekly
Accepts GuestsHas Sponsors
Podcast Overview
Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary information to make better business and process decisions. The Evaluating Biopharma podcast is a reproduction of content originally presented at recent Evaluating Biopharma digital and educational networking events.
Language
🇺🇲
Publishing Since
9/13/2022
Reach the team behind Evaluating Biopharma
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
October 14, 2025
Preview: Bo Wiinberg on Bridging Research and Trials with Cell-Based Therapies
Bo Wiinberg, Chief Business Development Officer at Novo Nordisk Foundation Cellerator, discusses with Ran Zheng, CEO of Landmark Bio, how cell therapies bridge research and clinical trials for incurable diseases.
November 12, 2024
Episode: 23 - An Industry Veteran’s Insight on Data Governance and Provenance
Host Ben Locwin interviews Scott Endicott, executive leader of Healthcare Solutions Integration, on achieving essential data governance and provenance for AI and ML models in biopharma.
October 8, 2024
Episode: 22 - Insider’s Advice for Starting, Growing, Exiting a Biotech
Host Ben Locwin interviews Chris Major, founder and partner of BioProcess360 Partners, on strategies for launching, scaling, and exiting biotech ventures.
25 total episodes available
Recent guests on Evaluating Biopharma
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Bo Wiinberg
Guest
Scott Endicott
Guest
Chris Major
Guest
Tony Arulanandam
Guest
Mara Strandlund
Guest
Niamh Alix
Guest
Joaquim Vives
Guest
Dr Stefan Schmidt
Guest
Jamie Martin
Guest
Brian Tham
Guest
Nesredin Mussa PhD
Guest
Deep-dive analytics for Evaluating Biopharma
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Evaluating Biopharma?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.